Health care-associated infections (HAIs), including Clostridioides difficile infection (CDI), Candida auris, and multidrug-resistant organisms (MDROs), persist as significant challenges for U.S. hospitals despite advancements in infection management, environmental cleaning, and isolation protocols. These infections pose a huge threat to patients and health care staff. But at the bedside, there is one persistent issue that seems more overwhelming and messier than other protocols dealing with fecal incontinence in critically ill patients who are already at risk.
For clinical staff in intensive care units (ICUs), transplant centers, oncology wards, and long-term acute care hospitals, fecal incontinence is not just a matter of comfort or hygiene; it represents a substantial clinical challenge. It is a common cause of infections spreading in the environment, staff exposure, longer periods of isolation, and secondary transmission. When inadequately managed, it can sustain a cycle of infection that undermines even strict infection programs.
Fecal incontinence as a catalyst for infections
Fecal incontinence impacts a large percentage of critically ill patients, especially in the ICU, where sedation, neurological issues, antibiotic exposure, and enteral feeding lead to high-volume liquid stool. In this situation, patient conditions can keep these pathogens alive for a long time. Stool from patients with active CDIs has a lot of spores present in it; organisms like Candida auris are known to stay in the environment and spread around in clinical settings.
When stool is not managed properly, it spreads to linens, skin, equipment, and nearby surroundings that clinical staff regularly interact with, making it easier for these infections to spread through everyday care.
Why current solutions are not sufficient
In hospitals in the U.S., the most common methods to deal with fecal incontinence are absorbent pads and adult diapers. They are easily available, but do not really control the source. Instead, stool remains around the patient and the area around them, which can cause damage to the skin due to the moisture, and increases the risk of infection. Frequent changes, often several times per shift, take up a lot of staff time and put nurses at risk without preventing contamination.
To fix some of these problems, indwelling balloon catheters were introduced. In some cases, they make some of the work simpler, but how well they work in practice may vary. Leakage persists, and the risk of hurting mucosa or how critical patients may handle it stops some groups from using it.
Putting source control into practice
These issues lead to a larger, more prevalent problem: the difference between what we know about preventing infections and what actually goes on at the bedside. From a clinical standpoint, this prompts a significant inquiry: Is not fecal incontinence to be regarded more explicitly as an issue of source control?
There are new emerging methods of stool management paving the way, one of them being an automated stool management system that diverts stool away from the patient and the surrounding environment, rather than just passively containing it. The goal is in line with the basic principles of infection prevention: reducing the contamination of the environment, limiting exposure, and protecting both patients and staff.
Effects on operations and clinical tasks
Improvements in stool management have real-world effects on how hospitals operate. Better stool management for patients with CDI may reduce environmental contamination, making frequent linen changes easier and possibly shortening hospital stays and the severity of isolation precautions. For doctors and nurses, this could mean less exposure and less time spent dealing with recurrent contamination.
These factors are especially essential now as there is an increase in staffing shortages and more patients in need of critical care. During outbreaks of organisms like Candida auris or other MDROs, where environmental persistence is a key factor in transmission, it is of heightened importance to curb contamination at the bedside from recurring.
Reframing the management of fecal incontinence
The persistent challenge of CDI and the emergence of resistant organisms underscore a disparity between infection control theory and routine clinical practice. Traditionally, nursing care workflows have been used to deal with fecal incontinence instead of infection prevention strategies. But in actual clinical settings, critically ill patients not being able to control their stool seems to increase transmission, isolation lasts longer, and uses more resources. Reframing fecal incontinence as an aspect of infection prevention, rather than as an isolated issue, may facilitate the closure of this gap.
In hospitals, fecal incontinence is often considered more of a secondary problem. In the context of CDI, Candida auris, and MDROs, it is more precisely regarded as a persistent and adaptable source of infection risk. Conventional methods are not able to maintain continuous source control and may necessitate clinicians to address the repercussions of persistent contamination. As hospitals continue to deal with infections that arise from drug resistance, paying more attention to bedside stool containment could be a useful and underused way to improve infection prevention efforts.
Deanna Vargo and Karen Lou Kennedy-Evans are nurse executives. Simone Hugar is a health care executive.
